Stephen Hoge, President at Moderna, Inc. (MRNA), sold 21,084 shares at $88.88 ($1.9M) on 2024-02-16, disclosed to the SEC on 2024-02-16.
Scheduled sale ($1.9M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.88 | 10,542 | $937K | 50.0% |
| 2 | $88.88 | 10,542 | $937K | 50.0% |
| Total | $88.88 avg | 21,084 | $1.9M | 100% |
| Filing → |
| MRNA | SELL | 2026-06-17 | $2.7M | — | Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |
| MRNA | SELL | 2026-02-25 | $7.8M | — | Filing → |